Cargando…
Distinct clinical features between acute and chronic progressive parenchymal neuro-Behçet disease: meta-analysis
Neuro-Behçet’s disease (NBD) is subcategorized into parenchymal-NBD (P-NBD) and non-parenchymal-NBD types. Recently, P-NBD has been further subdivided into acute P-NBD (A-P-NBD) and chronic progressive P-NBD (CP-P-NBD). Although an increasing number of studies have reported the various clinical feat...
Autores principales: | Ishido, Mizuho, Horita, Nobuyuki, Takeuchi, Masaki, Shibuya, Etsuko, Yamane, Takahiro, Kawagoe, Tatsukata, Ishido, Takehito, Minegishi, Kaoru, Yoshimi, Ryusuke, Kirino, Yohei, Hirohata, Shunsei, Ishigatsubo, Yoshiaki, Takeno, Mitsuhiro, Kaneko, Takeshi, Mizuki, Nobuhisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579041/ https://www.ncbi.nlm.nih.gov/pubmed/28860590 http://dx.doi.org/10.1038/s41598-017-09938-z |
Ejemplares similares
-
Clinical characteristics of neuro-Behcet’s disease in Japan: a multicenter retrospective analysis
por: Hirohata, Shunsei, et al.
Publicado: (2011) -
Recommendations for the Management of Neuro-Behçet's Disease by the Japanese National Research Committee for Behçet's Disease
por: Hirohata, Shunsei, et al.
Publicado: (2020) -
Clinical Course before and after Cataract and Glaucoma Surgery under Systemic Infliximab Therapy in Patients with Behçet's Disease
por: Nishida, Tomomi, et al.
Publicado: (2011) -
Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet’s disease in Japan
por: Soejima, Yutaro, et al.
Publicado: (2021) -
Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis
por: Ishigatsubo, Y, et al.
Publicado: (2015)